Cargando…

Seroprevalence of Bordetella pertussis toxin antibodies in children and adolescents in Tunis, Tunisia

Pertussis remains a public health concern in most countries. This cross-sectional study aims to investigate the distribution of pertussis toxin antibodies (anti-PT IgG) in Tunisian children and adolescents aged 3–18 years, to define optimal age for booster vaccination. Anti-PT IgG concentrations of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ben Fraj, I., Zghal, M., Hsairi, M., Kechrid, A., Smaoui, H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2019
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536764/ https://www.ncbi.nlm.nih.gov/pubmed/31364527 http://dx.doi.org/10.1017/S0950268819000840

Ejemplares similares

Seroprevalence of Bordetella pertussis antibodies in mothers and their newborn infants.
por: Gonik, Bernard, et al.
Publicado: (2005)

Seroprevalence of Pertussis in the Netherlands: Evidence for Increased Circulation of Bordetella pertussis
por: de Greeff, Sabine C., et al.
Publicado: (2010)

Secretion of Pertussis Toxin from Bordetella pertussis
por: Burns, Drusilla L.
Publicado: (2021)

Bordetella pertussis Strain Lacking Pertactin and Pertussis Toxin
por: Williams, Margaret M., et al.
Publicado: (2016)

COVID-19 in Tunisia (North Africa): Seroprevalence of SARS-CoV-2 in the General Population of the Capital City Tunis
por: Cherif, Ines, et al.
Publicado: (2022)

Bordetella pertussis Strains with Increased Toxin Production Associated with Pertussis Resurgence
por: Mooi, Frits R., et al.
Publicado: (2009)

Pasteurian Contributions to the Study of Bordetella pertussis Toxins
por: Locht, Camille
Publicado: (2023)

Socio-epidemiological and therapeutic profile of patients infected by HIV in 2011 at Tunis (Tunisia)
por: Mrabet, A, et al.
Publicado: (2014)

Baseline Seroprevalence of SARS-CoV-2 Specific Antibodies in Hot Spot Areas of Great Tunis, up to 3 Months Post Disease Onset in Tunisia
por: Dhaouadi, Sonia, et al.
Publicado: (2023)

Seroprevalence of Bordetella pertussis antibodies in adults in Hungary: results of an epidemiological cross-sectional study
por: Torzsa, Péter, et al.
Publicado: (2017)

Seroprevalence of IgA and IgM antibodies to Bordetella pertussis in healthy Japanese donors: Assessment for the serological diagnosis of pertussis
por: Fumimoto, Rei, et al.
Publicado: (2019)

Cross-sectional seroprevalence study of antibody to Bordetella pertussis toxin in western Saudi Arabia: is there a need for a vaccine booster dose for adolescents and young adults?
por: Farahat, Fayssal, et al.
Publicado: (2021)

Development of a qualitative assay for screening of Bordetella pertussis isolates for pertussis toxin production
por: Gates, Irina, et al.
Publicado: (2017)

Professional practices in the management of adrenal insufficiency in two tertiary referral hospitals (Tunis, Tunisia)
por: Chihaoui, Melika, et al.
Publicado: (2022)

Seroprevalence of Pertussis in The Gambia: Evidence for Continued Circulation of Bordetella pertussis Despite High Vaccination Rates
por: Scott, Susana, et al.
Publicado: (2015)

Pertussis Seroprevalence in Korean Adolescents and Adults Using Anti-Pertussis Toxin Immunoglobulin G
por: Lee, Soo Young, et al.
Publicado: (2014)

Pertussis Toxin Stimulates IL-17 Production in Response to Bordetella pertussis Infection in Mice
por: Andreasen, Charlotte, et al.
Publicado: (2009)

Blockade of the Adenylate Cyclase Toxin Synergizes with Opsonizing Antibodies to Protect Mice against Bordetella pertussis
por: DiVenere, Andrea M., et al.
Publicado: (2022)

Production of Highly Active Recombinant Dermonecrotic Toxin of Bordetella Pertussis
por: Stanek, Ondrej, et al.
Publicado: (2020)

Domperidone Inhibits Clostridium botulinum C2 Toxin and Bordetella pertussis Toxin
por: Jia, Jinfang, et al.
Publicado: (2023)

Analysis of Bordetella pertussis pertactin and pertussis toxin types from Queensland, Australia, 1999–2003
por: Byrne, Shane, et al.
Publicado: (2006)

A novel vaccine formulation candidate based on lipooligosaccharides and pertussis toxin against Bordetella pertussis
por: Gao, Jingjing, et al.
Publicado: (2023)

Does working in hospital increases seroprevalence and carrier state against Bordetella pertussis?
por: Naeini, Alireza Emami, et al.
Publicado: (2015)

Antibody Specificity Following a Recent Bordetella pertussis Infection in Adolescence Is Correlated With the Pertussis Vaccine Received in Childhood
por: Raeven, René H. M., et al.
Publicado: (2019)

Disease prevalence among young dogs in Grand Tunis, Tunisia: A retrospective study
por: Tagorti, Ghada
Publicado: (2019)

Etymologia:Bordetella pertussis
Publicado: (2010)

Reproductive Cycle of Marphysa sanguinea (Montagu, 1815) (Polychaeta: Eunicidae) in the Lagoon of Tunis
por: El Barhoumi, Monia, et al.
Publicado: (2013)

Bioengineering of Bordetella pertussis Adenylate Cyclase Toxin for Antigen-Delivery and Immunotherapy
por: Chenal, Alexandre, et al.
Publicado: (2018)

Novel murine model reveals an early role for pertussis toxin in disrupting neonatal immunity to Bordetella pertussis
por: Sedney, Colleen J., et al.
Publicado: (2023)

Prevalence, Genotype Distribution and Risk Factors for Cervical Human Papillomavirus Infection in the Grand Tunis Region, Tunisia
por: Ardhaoui, Monia, et al.
Publicado: (2016)

The BvgAS Regulon of Bordetella pertussis
por: Moon, Kyung, et al.
Publicado: (2017)

Bordetella pertussis, Finland and France
por: Caro, Valérie, et al.
Publicado: (2006)

Bordetella pertussis Isolates, Finland
por: Mäkinen, Johanna, et al.
Publicado: (2005)

Pharmacological Cyclophilin Inhibitors Prevent Intoxication of Mammalian Cells with Bordetella pertussis Toxin
por: Ernst, Katharina, et al.
Publicado: (2018)

Demyelination Lesions Do Not Correlate with Clinical Manifestations by Bordetella pertussis Toxin Concentrations
por: Perussolo, Maiara Carolina, et al.
Publicado: (2022)

Construction of Bordetella pertussis strains with enhanced production of genetically-inactivated Pertussis Toxin and Pertactin by unmarked allelic exchange
por: Buasri, Wasin, et al.
Publicado: (2012)

Bordetella pertussis Infection Exacerbates Influenza Virus Infection through Pertussis Toxin-Mediated Suppression of Innate Immunity
por: Ayala, Victor I., et al.
Publicado: (2011)

Asymptomatic transmission and the resurgence of Bordetella pertussis
por: Althouse, Benjamin M., et al.
Publicado: (2015)

Risk factors for Bordetella pertussis disease in hospitalized children
por: Muloiwa, Rudzani, et al.
Publicado: (2020)

Characterization of the Intrinsic Phospholipase A1 Activity of Bordetella pertussis Adenylate Cyclase Toxin
por: González-Bullón, David, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_mvvrojm7umf84ghsq5i07eht15